Drew specializes in preparing and prosecuting domestic and international patent applications and preparing non-infringement and invalidity opinions for clients in the chemical and pharmaceutical industries. Drew also has extensive experience in post-grant practice.

Drew has experience in various technological areas including polymers, pesticides, pharmaceuticals, nonwovens, paints and coatings, oil and gas, cosmetics, biofuels, batteries, nanoparticles, inks, fly ash chemistry, drug delivery systems, genetically modified crops, adhesives, asphalt formulations, and pulp and paper chemistry.

Drew has lectured on various topics of intellectual property law to international audiences and nationally for continuing legal education credit on topics such as inter partes review (IPR), including IPR in pharmaceutical cases, properties and test methods, ranges in patent claims, and patent profanity.

Drew is a frequent participant on international working committees addressing topics such as prior user rights, grace periods, post-grant amendment of patent claims, the use of prosecution histories in post-grant proceedings, patentability criteria for inventiveness/non-obviousness, the person of skill in the art, and selection inventions as they relate to inventiveness/non-obviousness.


Georgia Institute of Technology, B.S., Chemical Engineering, with highest honors

University of North Carolina, J.D.


  • Georgia
  • North Carolina
  • U.S. Patent and Trademark Office
  • Experience

    • Principal, Fish & Richardson P.C.
    • Partner, Head of Chemical and Pharmaceutical Patents Group, Alston & Bird LLP
  • Publications & Presentations

    • Supreme Court Decision Impacts Product Launch Strategy,” June 24, 2016.

    • Disclosure Activities in University Settings,” August 12, 2015.

    • Presenter: “Inter Partes Review (IPR),” CLE presentation related to IPR (May 2014).

    • Presenter: “Maximizing Value Through Mindful U.S. Prosecution,” CLE presentation related to patent profanity, ranges, properties and test methods, inventorship and the USPTO guidelines (April 2014).

    • Co-author of: “The Metal Oxide Nanoparticle Patent Landscape,” Rishi Gupta, Kimberlynn Davis, Christopher Ramsey, Andrew Meunier, and Kelly Kordzik, 6 Nanotechnology Law & Business (Issue 3, 2009).

    • Co-Author of: “Royalty Rate Trends and Valuation in Patent and Technology Licensing,” Aspen Law & Business Journal, co-authored the Journal‘s Licensing Update annually from 2000-2007.

    • Presenter: “Maximizing IP Value in an Economic Downturn.”; Fish & Richardson Munich Seminar, 2009.

    • Presenter: “When is an Invention “Obvious”? Practical Implications for Dealing with Shifting Legal Standards.”; Fish & Richardson Munich Seminar, 2008.

    • Presented at the 2005 and 2006 AIPPI U.S. Annual Meetings on Working Question Q189 – Post-Grant Amendment of Patent Claims.

  • Membership & Affiliations

    • AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle)
    • AIPPI Secretary of International Special Committee Related to Patents (Q228) 2014 - present
    • AIPPI EPO Liaison Council 2012 - present
    • AIPPI U.S. Group Secretary 2010 - 2013
    • AIPPI U.S. Group Executive Committee 2006 - 2010
    • Member, AIPLA Chemical Practice and International and Foreign Law Committees
    • Member, Georgia Bar IP Section